Skip to main content
Screener/Healthcare/Biotechnology

KYMR — Kymera Therapeutics, Inc.

NASDAQ
$97.61-2.13 (-2.14%)
Mid CapHealthcareFastest GrowingHigh Beta
$36.65
$105.00
$94.62
$100.69
EPS (TTM)$-3.58
P/E Ratio-22.72
Dividend Yield—
Market Cap$7.39B
Volume1.09M
Prev Close$99.45
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$34.4M-$69.2M$-0.710.0%-201.5%
Q4 '25$2.9M-$87.0M$-0.982763.6%-3043.0%
Q3 '25$2.8M-$82.2M$-0.94-2580.7%-2973.0%
Q2 '25$11.5M-$76.6M$-0.9581.8%-667.6%
Q1 '25$22.1M-$65.6M$-0.82100.0%-296.7%
Q4 '24$7.4M-$70.8M$-0.88100.0%-956.9%
Q3 '24$3.7M-$62.5M$-0.82100.0%-1670.3%
Q2 '24$25.6M-$42.1M$-0.58100.0%-164.0%
Get Your Daily Market Recap